ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,924 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryHorgenJantar GmbH
Jantar GmbH Logo
Verified· 2 sources

Jantar GmbH

Summary

About the company

The core activity of Jantar GmbH is the development of pharmaceutical products, particularly research and development (R&D) of medications for the treatment of rhinosinusitis, specifically with the active ingredient JT-1 for nasal spray application.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Development of Dicholinsuccinate for chronic rhinosinusitis
Preclinical development, active substance synthesis, drug product manufacturing, analytics, stability and toxicology for Dicholinsuccinate as a nasal spray for chronic rhinosinusitis.
Clinical development and Phase III studies
Proof-of-concept studies in patients with chronic rhinosinusitis as well as planned controlled, randomized Phase III study as a basis for marketing authorization.
Licensing and cooperation for consumer health partners
Search for an international partner for a licensing and cooperation agreement to continue the clinical and commercial development of a nasal spray.
Comparisons

Jantar GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Jantar GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Jantar GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Schleifetobelweg 3
8810 Horgen

At a glance

Legal form
Limited Liability Company
UID
CHE-360.505.305
Founded
2015 · 11 years
Last commercial register change
April 17, 2023
Employees
1 to 10

Knowledge

No knowledge articles yet

Once Jantar GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

NT
Numab Therapeutics AG
Horgen
DT
Denali Therapeutics CH GmbH
Zurich
OP
Otsuka Pharmaceutical (Switzerland) GmbH
Glattbrugg
SA
Stallergenes AG
Dietlikon
MA
Melisana AG
Zurich
MP
Molecular Partners AG
Schlieren
CA
CUTISS AG
Schlieren
BT
BEO Therapeutics AG
Zurich